Campbell & Co Investment Adviser Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alliant Energy
LNT
|
+$2.26M |
| 2 |
Amgen
AMGN
|
+$2.06M |
| 3 |
ALE
Allete
ALE
|
+$2.03M |
| 4 |
TSMC
TSM
|
+$2.02M |
| 5 |
Telus
TU
|
+$1.98M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
GSK
GSK
|
+$5.7M |
| 2 |
Scotiabank
BNS
|
+$3.49M |
| 3 |
AstraZeneca
AZN
|
+$3.32M |
| 4 |
SEE
Sealed Air
SEE
|
+$2.73M |
| 5 |
A.O. Smith
AOS
|
+$2.56M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 15.42% |
| 2 | Industrials | 14.97% |
| 3 | Technology | 12.87% |
| 4 | Consumer Discretionary | 12.79% |
| 5 | Financials | 10.59% |
Similar funds
Campbell & Co Investment Adviser's Q4 2022 Portfolio in Review
As of Q4 2022, Campbell & Co Investment Adviser held 1,064 positions worth $418M, down 5% from $440M the previous quarter. Its ten largest holdings account for 5% of the portfolio.
Campbell & Co Investment Adviser withdrew a net $45.5M in Q4 2022, closing 328 positions and reducing 186 holdings. Its most notable exit was GSK, an estimated $5.7M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 15% of assets, down from 19% a quarter earlier, followed by Industrials and Technology.
Against the trend, Campbell & Co Investment Adviser opened a new position in Alliant Energy worth $2.34M.
- Campbell & Co Investment Adviser's largest Q4 2022 buy was Alliant Energy: 42,303 shares worth $2.34M.
- Campbell & Co Investment Adviser added most to Diageo in Q4 2022, an estimated $1.8M increase.
- Campbell & Co Investment Adviser's biggest Q4 2022 reduction was Scotiabank, cutting an estimated $3.49M.
- Campbell & Co Investment Adviser fully exited GSK in Q4 2022, selling an estimated $5.7M.
- Campbell & Co Investment Adviser's ten largest holdings make up 5% of its $418M portfolio in Q4 2022.
- Campbell & Co Investment Adviser opened 376 new positions and closed 328 in Q4 2022.
- Campbell & Co Investment Adviser's portfolio value fell 5% quarter-over-quarter to $418M.
Based on Campbell & Co Investment Adviser's 13F filing for Q4 2022, filed 14 Feb 2023.